Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1159308910 | 11593089 | 10 | F | 20150710 | 20160830 | 20151005 | 20160909 | EXP | JP-AMGEN-JPNCT2015096591 | AMGEN | 70.00 | YR | E | F | Y | 48.40000 | KG | 20160909 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1159308910 | 11593089 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 6 MG/KG, Q2WEEKS | 125147 | 6 | MG/KG | SOLUTION FOR INJECTION | QOW | ||||||
1159308910 | 11593089 | 2 | SS | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous bolus | 400 MG/M2, Q2WEEKS | U | 0 | 400 | MG/M**2 | QOW | ||||||
1159308910 | 11593089 | 3 | SS | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 2400 MG/M2, Q2WEEKS | U | 0 | 2400 | MG/M**2 | QOW | ||||||
1159308910 | 11593089 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 85 MG/M2, Q2WEEKS | U | 0 | 85 | MG/M**2 | QOW | ||||||
1159308910 | 11593089 | 5 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 200 MG/M2, Q2WEEKS | 1200 | MG/M2 | U | 0 | 200 | MG/M**2 | QOW | ||||
1159308910 | 11593089 | 6 | C | HIRUDOID /00723701/ | PENTOSAN POLYSULFATE SODIUM | 1 | Transdermal | UNK | U | 0 | |||||||||
1159308910 | 11593089 | 7 | C | LOCOID | HYDROCORTISONE BUTYRATE | 1 | Transdermal | UNK | U | 0 | |||||||||
1159308910 | 11593089 | 8 | C | ANTEBATE | BETAMETHASONE DIPROPIONATE | 1 | Transdermal | UNK | U | 0 | |||||||||
1159308910 | 11593089 | 9 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 0.5 MG, BID | 4 | MG | U | 0 | .5 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1159308910 | 11593089 | 1 | Colon cancer |
1159308910 | 11593089 | 2 | Colon cancer |
1159308910 | 11593089 | 4 | Colon cancer |
1159308910 | 11593089 | 5 | Colon cancer |
1159308910 | 11593089 | 6 | Prophylaxis |
1159308910 | 11593089 | 7 | Prophylaxis |
1159308910 | 11593089 | 8 | Prophylaxis |
1159308910 | 11593089 | 9 | Prophylaxis of nausea and vomiting |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1159308910 | 11593089 | OT |
1159308910 | 11593089 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1159308910 | 11593089 | Abdominal pain upper | |
1159308910 | 11593089 | Decreased appetite | |
1159308910 | 11593089 | Dermatitis bullous | |
1159308910 | 11593089 | Dysgeusia | |
1159308910 | 11593089 | Fatigue | |
1159308910 | 11593089 | Nausea | |
1159308910 | 11593089 | Neuropathy peripheral | |
1159308910 | 11593089 | Neutrophil count decreased | |
1159308910 | 11593089 | Pancytopenia | |
1159308910 | 11593089 | Platelet count decreased | |
1159308910 | 11593089 | Rash | |
1159308910 | 11593089 | Skin disorder | |
1159308910 | 11593089 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1159308910 | 11593089 | 1 | 20150709 | 0 | ||
1159308910 | 11593089 | 2 | 20150709 | 0 | ||
1159308910 | 11593089 | 3 | 20150709 | 0 | ||
1159308910 | 11593089 | 4 | 20150709 | 0 | ||
1159308910 | 11593089 | 5 | 20150709 | 20150917 | 0 | |
1159308910 | 11593089 | 6 | 20150708 | 0 | ||
1159308910 | 11593089 | 7 | 20150708 | 0 | ||
1159308910 | 11593089 | 8 | 20150708 | 0 | ||
1159308910 | 11593089 | 9 | 20150918 | 20150921 | 0 |